Novo Nordisk A/S secures FDA nod for oral Wegovy, expanding obesity treatment options. Click for how oral GLP-1 therapies ...
Eight-month-old Rowan Edgell was diagnosed with a rare type of infantile fibrosarcoma at only a few months old. After several ...
Novo Nordisk A/S's oral Wegovy wins FDA approval, promising strong 2026 growth with market exclusivity and competitive ...
The FDA approved the first oral GLP-1 for lowering body weight according to a press release from Novo Nordisk. Oral ...
GLP-1 medicines have been utilised for the treatment of diabetes; however, they are now emerging as important topics for the treatment of obesity ...
Prescription NAD+ Injection Access, At-Home Administration Models, Compounding Standards, and What Consumers Should Know ...
The top 10 PharmTech videos of the year cover advanced therapies, high-concentration biologics, major mergers and ...
Flow Space on MSN
Update: FDA approves oral version of Wegovy, first GLP-1 pill approved specifically for weight management
Just before the end of 2025, an oral version of a GLP-1 drug specifically used for weight management moved much closer to ...
The Wegovy pill is FDA-approved to reduce excess body weight and maintain weight reduction long-term in adults who have ...
Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma Approval based on global phase 3 program in children demonstrating Dupixent significantly ...
Street dog Molly battled painful mange in Bali, but thanks to local rescuers and treatment, she’s now healing, happy, and ...
Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback